ConductScience.org, home

Paper39259258

Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin.

Kumar G and 8 others. Ther Deliv, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin. Papers, record 39259258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39259258

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin.
PubMed
Journal
Ther Deliv
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.64, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumar GGirishhttps://orcid.org/0000-0002-2917-3277
2Jain PPushpika
3Virmani TTarunhttps://orcid.org/0000-0002-1615-5213
4Sharma AAshwanihttps://orcid.org/0000-0001-9399-0856
5Akhtar MSMd Sayeed
6Aldosari SASaad A
7Khan MFMohd Faiyaz
8Duarte SODSofia O Dhttps://orcid.org/0000-0002-7945-1474
9Fonte PPedrohttps://orcid.org/0000-0002-1115-9282

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApigeninMajor topic
Humans
Animals
Biological Availability
Solubility
Drug Delivery Systems
Nanoparticles
Nanotechnology
Nanoparticle Drug Delivery System

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
RGP2/317/45Deanship of Research and Graduate Studies at King Khalid UniversityPubMed
LA/P/0101/2020Fundação para a Ciência e a TecnologiaPubMed

Source PubMed

Download CSV of grants

References93

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135495935Protective Roles of Apigenin Against Cardiometabolic Diseases: A Systematic Review.Front Nutr2022https://conductscience.org/library/papers/35495935PubMed
234084146Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers?Front Pharmacol2021https://conductscience.org/library/papers/34084146PubMed
324269286Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes.Int J Pharm2014https://conductscience.org/library/papers/24269286PubMed
424971492Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway.Antiviral Res2014https://conductscience.org/library/papers/24971492PubMed
524266259Micelles of TPGS modified apigenin phospholipid complex for oral administration: preparation, in vitro and in vivo evaluation.J Biomed Nanotechnol2013https://conductscience.org/library/papers/24266259PubMed
625565442How to overcome the limitations of current insulin administration with new non-invasive delivery systems.Ther Deliv2015https://conductscience.org/library/papers/25565442PubMed
734740050Apigenin-oxymatrine binary co-amorphous mixture: Enhanced solubility, bioavailability, and anti-inflammatory effect.Food Chem2022https://conductscience.org/library/papers/34740050PubMed
835816909Polymer-based drug delivery systems for anticancer drugs: A systematic review.Cancer Treat Res Commun2022https://conductscience.org/library/papers/35816909PubMed
931416279The Stability and Activity Changes of Apigenin and Luteolin in Human Cervical Cancer Hela Cells in Response to Heat Treatment and Fe2+/Cu2+ Addition.Foods2019https://conductscience.org/library/papers/31416279PubMed
1036007853Apigenin in cancer therapy: From mechanism of action to nano-therapeutic agent.Food Chem Toxicol2022https://conductscience.org/library/papers/36007853PubMed
1135096502A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents.Bionanoscience2022https://conductscience.org/library/papers/35096502PubMed
1236915508Apigenin-coated gold nanoparticles as a cardioprotective strategy against doxorubicin-induced cardiotoxicity in male rats via reducing apoptosis.Heliyon2023https://conductscience.org/library/papers/36915508PubMed
1330986716Apoptosis induced by luteolin in breast cancer: Mechanistic and therapeutic perspectives.Phytomedicine2019https://conductscience.org/library/papers/30986716PubMed
1437447573Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates.Polymers (Basel)2023https://conductscience.org/library/papers/37447573PubMed
1531759101Dendrimers in the context of nanomedicine.Int J Pharm2020https://conductscience.org/library/papers/31759101PubMed
1634866166Nanoparticles for Cancer Therapy: Current Progress and Challenges.Nanoscale Res Lett2021https://conductscience.org/library/papers/34866166PubMed
1733583219Liposomes and transferosomes: a breakthrough in topical and transdermal delivery.Ther Deliv2021https://conductscience.org/library/papers/33583219PubMed
1834996205Aptamer-Conjugated Apigenin Nanoparticles To Target Colorectal Carcinoma: A Promising Safe Alternative of Colorectal Cancer Chemotherapy.ACS Appl Bio Mater2018https://conductscience.org/library/papers/34996205PubMed
1938026534Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment.Int J Nanomedicine2023https://conductscience.org/library/papers/38026534PubMed
2036145264Bilosomes as Nanoplatform for Oral Delivery and Modulated In Vivo Antimicrobial Activity of Lycopene.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36145264PubMed

See all 93 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42910236Advancements in Nanomedicine Platforms and Solid-State Engineering for Enhancing the Solubility of Apigenin: A Narrative Review.Int J Nanomedicine2026https://conductscience.org/library/papers/42910236PubMed
42683198Natural Medicines Modulating Tumor Perineural Invasion: Regulatory Mechanisms and Therapeutic Potential.Drug Des Devel Ther2026https://conductscience.org/library/papers/42683198PubMed
42365116Unveiling the potential of solid lipid nanoparticles of apigenin-Cu(II) coordinated nanocomplex in colon cancer.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42365116PubMed
41323822Overcoming the Low Bioavailability of Apigenin: The Therapeutic Efficacy for Androgenetic Alopecia Through Topical Administration.Food Sci Nutr2025https://conductscience.org/library/papers/41323822PubMed
40806510Isorhamnetin: Reviewing Recent Developments in Anticancer Mechanisms and Nanoformulation-Driven Delivery.Int J Mol Sci2025https://conductscience.org/library/papers/40806510PubMed
40788176Unlocking the full potential of piperine-loaded nanocarriers for cancer treatment.Ther Deliv2025https://conductscience.org/library/papers/40788176PubMed
39686635An Updated Review Deciphering Apigenin Nanostructures as Promising Therapeutic Efficiency in Human Carcinomas.Curr Med Chem2025https://conductscience.org/library/papers/39686635PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39259258

GET https://conductscience.org/api/papers/v1/39259258/references?page=2